Overview
Empty follicle syndrome (EFS) is a perplexing condition encountered in assisted reproductive technology (ART) cycles, characterized by the absence of an oocyte retrieval despite evidence of a mature follicle(s) on ultrasound and hormonal markers indicative of ovulation readiness. This syndrome poses significant challenges for patients undergoing fertility treatments, often leading to cycle cancellation and emotional distress. The pathophysiology of EFS remains incompletely understood, but recent insights into the structural dynamics of ovarian follicles offer potential avenues for further exploration. Understanding the nuances of follicle development and rupture mechanisms is crucial for improving diagnostic accuracy and clinical management strategies.
Pathophysiology
The structural integrity and dynamic changes within ovarian follicles play a critical role in the occurrence of empty follicle syndrome. Recent research has identified actin- and myosin-like immunoreactivity within the cells of the theca externa, suggesting the presence of non-vascular contractile cells within human ovarian follicle walls [PMID:2197116]. These contractile elements may contribute to the mechanical processes involved in follicle maturation and rupture. During normal folliculogenesis, these contractile forces are hypothesized to facilitate the expulsion of the oocyte during ovulation. However, in cases of EFS, disruptions in these contractile mechanisms or structural abnormalities might prevent the oocyte from being released into the follicular fluid, leading to its apparent absence upon aspiration. This finding underscores the importance of considering both functional and structural aspects of follicle dynamics in the pathogenesis of EFS.
In clinical practice, the interplay between hormonal signaling and mechanical forces within the follicle wall is crucial. Hormonal cues, such as luteinizing hormone (LH) surges, typically trigger the final maturation and rupture of the follicle. However, when these mechanical processes fail, oocytes may remain entrapped within the follicle wall, resulting in EFS. Further research is needed to elucidate how disruptions in these intricate processes can be identified and potentially mitigated to prevent EFS in ART cycles.
Diagnosis
Diagnosing empty follicle syndrome involves a meticulous approach to both clinical monitoring and histological evaluation of ovarian follicles. Ultrasonographic monitoring during the follicular phase is standard practice, tracking follicle growth and maturation based on size and echogenicity. However, the accuracy of these assessments can be influenced by various factors, including the timing of the ultrasound and the skill of the operator. Hormonal markers, such as estradiol levels and progesterone precursors, also guide the decision for oocyte retrieval but do not definitively predict oocyte presence.
Histological evaluation of retrieved material is often necessary to confirm EFS definitively. A critical aspect highlighted by recent studies is the variability introduced by different fixative techniques and fixation durations [PMID:33988116]. Fixatives such as neutral buffered formalin (NBF), Carnoy's (CAR), Davidson's (DAV), and paraformaldehyde (PFA), along with fixation times of 12 hours versus 24 hours, have been shown to significantly impact the preservation of primordial and primary follicles [PMID:33988116]. Standardization of these protocols is essential to minimize diagnostic variability and ensure consistent morphological assessment. For instance, Davidson's solution (DAV) has emerged as a reliable fixative, maintaining follicle integrity across different fixation durations [PMID:33988116]. Clinicians should therefore prioritize adherence to standardized histological protocols to enhance diagnostic accuracy and reduce the incidence of misdiagnosis in cases of suspected EFS.
Management
The management of empty follicle syndrome primarily focuses on optimizing future ART cycles to minimize recurrence and improve outcomes. Given the unpredictable nature of EFS, several strategies can be employed to enhance the chances of successful oocyte retrieval in subsequent attempts:
In clinical practice, a multidisciplinary approach involving endocrinologists, reproductive endocrinologists, and mental health professionals can significantly enhance patient care and outcomes following an EFS event. Continuous research into the underlying mechanisms of EFS will further refine these management strategies, aiming to reduce its incidence and improve overall fertility treatment success rates.
Key Recommendations
By adhering to these recommendations, clinicians can enhance diagnostic accuracy, improve patient outcomes, and mitigate the psychological burden associated with empty follicle syndrome in assisted reproductive technology cycles.
References
1 Brito DCC, Ñaupas LVS, Souza SS, Alcântara GLH, Figueiredo JR, Santos RR et al.. Interference of fixatives and fixation period on the morphologic analysis of ovarian preantral follicles. Zygote (Cambridge, England) 2022. link 2 Walles B, Gröschel-Stewart U, Kannisto P, Owman C, Sjöberg NO, Unsicker K. Immunocytochemical demonstration of contractile cells in the human ovarian follicle. Experientia 1990. link
2 papers cited of 3 indexed.